PMID: 6987961Mar 1, 1980Paper

Lung transplantation: better survival results after graft pretreatment with concanavalin A or chondroitin sulfate

The Annals of Thoracic Surgery
L H Toledo-PereyraM Chee

Abstract

Pretreatment of the lung graft with concanavalin A (Con A) or chondroitin sulfate (CIS) was used to modify the lung allograft response after transplantation into moderately immunosuppressed (low doses of azathioprine and prednisone) recipients. Significant (p less than 0.05) prolongation of survival was observed after graft pretreatment. Pneumonia and rejection were the most frequent causes of death for all groups of dogs. However, only 3 out of 6 animals from each of the groups with pretreated grafts died of pneumonia or rejection, whereas 5 of the 6 animals in the control group died of these causes. Furthermore, when rejection occurred in the dogs with lung grafts pretreated with Con A or CIS, it was considerably delayed compared with the controls. Partial pressure of arterial oxygen, chest roentgenograms, and lung histology were good indicators of lung viability after transplantation.

References

Mar 1, 1977·World Journal of Surgery·F J Veith, S K Koerner
Nov 1, 1977·The Annals of Thoracic Surgery·M GoldbergA Greenaway
May 1, 1976·Transplantation·D Steinmuller, D A Coleman
Oct 1, 1976·Transplantation·W C DeWolfJ Miller
Aug 1, 1973·The Annals of Thoracic Surgery·F J VeithM L Gliedman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.